These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8814542)

  • 21. 2-Methoxyestradiol inhibits bleomycin-induced systemic sclerosis through suppression of fibroblast activation.
    Zhu L; Song Y; Li M
    J Dermatol Sci; 2015 Jan; 77(1):63-70. PubMed ID: 25465161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The inhibitory effects of camptothecin, a topoisomerase I inhibitor, on collagen synthesis in fibroblasts from patients with systemic sclerosis.
    Czuwara-Ladykowska J; Makiela B; Smith EA; Trojanowska M; Rudnicka L
    Arthritis Res; 2001; 3(5):311-8. PubMed ID: 11549373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TGF-β-mediated downregulation of microRNA-196a contributes to the constitutive upregulated type I collagen expression in scleroderma dermal fibroblasts.
    Honda N; Jinnin M; Kajihara I; Makino T; Makino K; Masuguchi S; Fukushima S; Okamoto Y; Hasegawa M; Fujimoto M; Ihn H
    J Immunol; 2012 Apr; 188(7):3323-31. PubMed ID: 22379029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-6 and Type-I Collagen Production by Systemic Sclerosis Fibroblasts Are Differentially Regulated by Interleukin-17A in the Presence of Transforming Growth Factor-Beta 1.
    Dufour AM; Alvarez M; Russo B; Chizzolini C
    Front Immunol; 2018; 9():1865. PubMed ID: 30150989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EM703, the new derivative of erythromycin, inhibits transcription of type I collagen in normal and scleroderma fibroblasts.
    Ikeda H; Sunazuka T; Suzuki H; Hamasaki Y; Yamazaki S; Omura S; Hatamochi A
    J Dermatol Sci; 2008 Mar; 49(3):195-205. PubMed ID: 18036782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis.
    Distler O; Pap T; Kowal-Bielecka O; Meyringer R; Guiducci S; Landthaler M; Schölmerich J; Michel BA; Gay RE; Matucci-Cerinic M; Gay S; Müller-Ladner U
    Arthritis Rheum; 2001 Nov; 44(11):2665-78. PubMed ID: 11710722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha.
    Chizzolini C; Parel Y; De Luca C; Tyndall A; Akesson A; Scheja A; Dayer JM
    Arthritis Rheum; 2003 Sep; 48(9):2593-604. PubMed ID: 13130479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blockade of endogenous transforming growth factor beta signaling prevents up-regulated collagen synthesis in scleroderma fibroblasts: association with increased expression of transforming growth factor beta receptors.
    Ihn H; Yamane K; Kubo M; Tamaki K
    Arthritis Rheum; 2001 Feb; 44(2):474-80. PubMed ID: 11229480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of collagen gene expression in systemic sclerosis dermal fibroblasts by mithramycin.
    Sandorfi N; Louneva N; Hitraya E; Hajnoczky G; Saitta B; Jimenez SA
    Ann Rheum Dis; 2005 Dec; 64(12):1685-91. PubMed ID: 15901633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of an IL1A gene segment that determines aberrant constitutive expression of interleukin-1 alpha in systemic sclerosis.
    Kawaguchi Y; Hara M; Kamatani N; Wright TM
    Arthritis Rheum; 2003 Jan; 48(1):193-202. PubMed ID: 12528119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dermatopontin expression is decreased in hypertrophic scar and systemic sclerosis skin fibroblasts and is regulated by transforming growth factor-beta1, interleukin-4, and matrix collagen.
    Kuroda K; Okamoto O; Shinkai H
    J Invest Dermatol; 1999 May; 112(5):706-10. PubMed ID: 10233760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-10 modulates type I collagen and matrix metalloprotease gene expression in cultured human skin fibroblasts.
    Reitamo S; Remitz A; Tamai K; Uitto J
    J Clin Invest; 1994 Dec; 94(6):2489-92. PubMed ID: 7989607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. alpha-melanocyte-stimulating hormone suppresses bleomycin-induced collagen synthesis and reduces tissue fibrosis in a mouse model of scleroderma: melanocortin peptides as a novel treatment strategy for scleroderma?
    Kokot A; Sindrilaru A; Schiller M; Sunderkötter C; Kerkhoff C; Eckes B; Scharffetter-Kochanek K; Luger TA; Böhm M
    Arthritis Rheum; 2009 Feb; 60(2):592-603. PubMed ID: 19180474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin 4 and prolonged hypoxia induce a higher gene expression of lysyl hydroxylase 2 and an altered cross-link pattern: important pathogenetic steps in early and late stage of systemic scleroderma?
    Brinckmann J; Kim S; Wu J; Reinhardt DP; Batmunkh C; Metzen E; Notbohm H; Bank RA; Krieg T; Hunzelmann N
    Matrix Biol; 2005 Oct; 24(7):459-68. PubMed ID: 16139999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Co-ordinate increase in the expression of type I and type III collagen genes in progressive systemic sclerosis fibroblasts.
    Jimenez SA; Feldman G; Bashey RI; Bienkowski R; Rosenbloom J
    Biochem J; 1986 Aug; 237(3):837-43. PubMed ID: 3800922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-29, a key regulator of collagen expression in systemic sclerosis.
    Maurer B; Stanczyk J; Jüngel A; Akhmetshina A; Trenkmann M; Brock M; Kowal-Bielecka O; Gay RE; Michel BA; Distler JH; Gay S; Distler O
    Arthritis Rheum; 2010 Jun; 62(6):1733-43. PubMed ID: 20201077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulatory mechanisms of collagen expression by interleukin-22 signaling in scleroderma fibroblasts.
    Sawamura S; Jinnin M; Inoue K; Yamane K; Honda N; Kajihara I; Makino T; Masuguchi S; Fukushima S; Ihn H
    J Dermatol Sci; 2018 Apr; 90(1):52-59. PubMed ID: 29336866
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of elements in the promoter region of the alpha1(I) procollagen gene involved in its up-regulated expression in systemic sclerosis.
    Hitraya EG; Varga J; Artlett CM; Jiménez SA
    Arthritis Rheum; 1998 Nov; 41(11):2048-58. PubMed ID: 9811061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Constitutively phosphorylated Smad3 interacts with Sp1 and p300 in scleroderma fibroblasts.
    Ihn H; Yamane K; Asano Y; Jinnin M; Tamaki K
    Rheumatology (Oxford); 2006 Feb; 45(2):157-65. PubMed ID: 16319104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptional activation of the type I collagen genes COL1A1 and COL1A2 in fibroblasts by interleukin-4: analysis of the functional collagen promoter sequences.
    Büttner C; Skupin A; Rieber EP
    J Cell Physiol; 2004 Feb; 198(2):248-58. PubMed ID: 14603527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.